Skip to main content

Catalent Completes $548.1M Common Stock Follow-on Offering

Press releases | June 15, 2020

Fried Frank acted as counsel to Catalent, Inc. in an all-primary follow-on offering of 7,750,000 shares of common stock at a price of US$70.72 per share, for an aggregate total amount of US$548.1 million. The net proceeds from this offering will be used to repay in full the US$200 million of outstanding borrowings under Catalent’s revolving credit facility under its senior secured credit facilities and for general corporate purposes, which may include working capital, capital expenditures, and funding its growth strategy through organic investments and potential future acquisitions. Catalent, Inc. is the leading global provider of advanced delivery technologies and development solutions for drugs, biologics, and consumer health products.

The Fried Frank team was led by corporate partners Daniel J. Bursky and Joshua T. Coleman and included tax partner Michael J. Alter, corporate associate Charles Stern, and tax associates Ryan L. Conley and Sarah M. Madigan. 


This communication is for general information only. It is not intended, nor should it be relied upon, as legal advice. In some jurisdictions, this may be considered attorney advertising. Please refer to the firm’s data policy page for further information.